Lonza Group AG / Key word(s): Annual Results Lonza Delivers Strong 2021 performance with 20% CER Sales Growth 26-Jan-2022 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is solely responsible for the content of this announcement. Ad Hoc Release Pursuant to Ar.
(PLX AI) - Lonza Obtains Order Preventing Infringement of Its Patents Covering the Cocoon Platform.• Adva Biotechnology Ltd. is enjoined from making, using, selling, offering to sell, and importing into
Lonza snapped up Codiak Biosciences' exosome manufacturing facility in Massachusetts, gaining access to technology that turns drug molecules into exosomes in order to selectively deliver treatments to target tissues and reduce toxicity. The two companies are forming a Center of Excellence for the development of exosome production and analytics technologies.
Tesoros vivos que superan los 80 años de edad diariolongino.cl - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from diariolongino.cl Daily Mail and Mail on Sunday newspapers.